-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Screening Tests
Screening Tools for Dementia and Cognitive Impairment in Hospitals: Validity and Accuracy (PLoS One)
Summary A Swiss systematic review investigated the diagnostic accuracy and validity of various tools for screening dementia and / or cognitive impairment in hospital patients. The aim was to provide up-to-date evidence for the choice of cognitive tests best suited … Continue reading
Posted in Acute Hospitals, BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Models of Dementia Care, Quick Insights, Systematic Reviews, UK, Universal Interest, Wales
Tagged 6-Item Cognitive Impairment Test (6-CIT), Abbreviated Mental Test Score (AMTS), Alzheimer’s Early Screening, Alzheimer’s Foundation of America’s National Memory Screening Program, Aneurin Bevan University Health Board (ABUHB), BBC Health News, BBC Wales News, Benefits of Detection and Early Intervention, Cantonal Hospital Lucerne, Cardiff's University Hospital of Wales, Case Finding, Case Finding for Patients with Dementia, Clinic for Neurology and Neurorehabilitation: Cantonal Hospital Lucerne, Clock Drawing Test, Clock Drawing Test (CDT), Cognitive Assessment Tools, Cognitive Impairment, Cognitive Performance Scale (CPS), Dementia and Mild Cognitive Impairment in Hospital Patients, Dementia Case Finding, Dementia Case Finding Scheme, Dementia Diagnosis, Dementia Screening, Dementia Screening Debate, Department of Health Sciences and Health Policy: University of Lucerne, Diagnosis and Referral, Diagnosis and Support, Diagnosis Gap, Diagnosis of Dementia, Diagnosis Rates, Diagnostic Accuracy, Dr Chineze Ivenso: Chair of Old Age Faculty at Royal College of Psychiatrists in Wales, Early Screening, Effectiveness of Early Detection and Treatment, Elective Inpatients, Improving Diagnosis, Medicare Annual Wellness Visit (United States), Mild Cognitive Impairment (MCI), Mild Cognitive Impairment in Hospital Patients, Mini Mental State Examination (MMSE), PLoS One, Positron Emission Tomography (PET), Professor Chris Marshall: Wales Research and Diagnostic PET Imaging Centre, Royal College of Psychiatrists in Wales, Screening, Screening for Cognitive Impairment, Screening for Cognitive Impairment in Hospital Patients, Screening for Dementia, Screening Instruments for Dementia and Mild Cognitive Impairment in Hospital Patients, Screening Programmes, Screening Tests, Six-Item Cognitive Impairment Test (6CIT), Switzerland, Time and Change (T&C) Test, University Hospital of Wales (UHW), University of Lucerne, Validity of Screening Tools for Dementia and Mild Cognitive Impairment, Wales Research and Diagnostic PET Imaging Centre, Welsh Government
Leave a comment
Questioning the Disproportionate Flood of Publications Praising the Benefits of Early Detection: Too Much of a Good Thing? (BMJ)
Summary A brief Norwegian review has highlighted an unbalanced surge in publications about the benefits of the earlier detection of diseases (which are typically taken unquestioningly as a “given”). The authors allege that articles discussing the benefits of early detection … Continue reading
Posted in Acute Hospitals, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Person-Centred Care, Quick Insights, Statistics, Universal Interest
Tagged Benefits of Early Detection, BMJ, BMJ Publishing Group Ltd, Department of Health Sciences in Gjøvik: Norwegian University of Science and Technology, Department of Public Health and Nursing: Norwegian University of Science and Technology, Early Detection of Disease, Early Diagnosis, Early Screening, General Health Checks in Adults, Harms From Overdiagnosis, Harms of Too Much Medicine, Health Screening Programmes, Improving Patient Safety, Improving Value in Diagnostic Services, Incentivised GP Health Checks, Lean and Quality Improvement, Less is More, Lowering Costs, Medical and Surgical Overtreatment, Medical Overuse, Medicalisation, Medicalising Unhappiness, Norway, Norwegian University of Science and Technology, Over-Diagnosis, Over-Medicalisation (Speculative Concept), Over-Treatment, Overdiagnosis and Overtreatment, Overuse of Diagnostic or Monitoring Tests / Procedures, Overuse of Medication, Patient Harms, Patient Safety, Protecting Resources and Promoting Value, Reducing Expenditure, Reducing Productive Waste, Screening, Screening Populations, Screening Programmes, Screening Tests, Timely Diagnosis, Too Much Medicine, Unnecessary Tests
Leave a comment
The Pros and Cons of Screening (Sense About Science / BMJ / BMC Geriatrics / BBC News / NHS England)
Summary The brief “Making Sense of Screening” guide attempts to inform public expectations about screening programmes. It offers insights into the limitations of what screening programmes are sometimes able to deliver. Common misconceptions about how screening works are addressed, with … Continue reading
Posted in BBC News, Charitable Bodies, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Models of Dementia Care, Quick Insights, UK, Universal Interest
Tagged Academic Unit of Psychiatry: University of Bristol, Advisory Board of Breast Screening, Association for Clinical Biochemistry and Laboratory Medicine, BBC Health News, BMJ, British Medical Journal (BMJ), Cambridge Institute of Public Health: University of Cambridge, Case Finding, Cognitive Screening, Dementia Screening, Dementia Screening Debate, Division of Psychiatry: University College London, Early Screening, Evidence Based Medicine Matters, Faculty of Medicine and Health Sciences: University of East Anglia, False Alarms, False Negatives, False Positives, Great Prostate Mistake, Great Prostate Mistake (PSA sic Promoting Stress and Anxiety), Harms From Overdiagnosis, Health Screening Programmes, Hedley Glencross: Portsmouth Hospitals NHS Trust, Independent Review of Adult Screening Programme in England (NHS England), Institute of Biomedical Science, Institute of Mental Health: University of Nottingham, International Journal of Geriatric Psychiatry, Joe O’Meara: Association for Clinical Biochemistry and Laboratory Medicine, Making Sense of Testing, Making Sense of Uncertainty, Mass Screening, National Breast Cancer Screening Programme, National Screening Committee, Nordic Cochrane Centre in Copenhagen, Overdiagnosis (Speculative Concept), Overdiagnosis and Overtreatment, Population Screening for Dementia Deyond Passive Case-Finding, Professor Sir Mike Richards: Review of Cancer Screening, PSA (Prostate Specific Antigen), Public Attitudes Expectations and Preferences, QRISK2 Calculator, Research Department of Primary Care and Population Health: University College London, Review of National Cancer Screening Programmes in England, Risk of Overdiagnosis Associated With Screening, Síle Lane: Sense About Science, Screening, Screening for Dementia, Screening Populations, Screening Programmes, Screening Tests, Screening: Counter-Intuitive Evidence, Sense About Science, Targeted Screening, UCL Medical School, UK National Screening Committee, University College London, University of Bristol, University of Cambridge, University of East Anglia, University of Nottingham, Watchful Waiting
Leave a comment
Literature Review on Olfaction (Sense of Smell) and Neurodegenerative Diseases (International Archives of Otorhinolaryngology)
Summary Loss of sense of smell may be involved in certain neurodegenerative diseases, including Parkinson Disease and Alzheimer’s Disease. This literature review examines the relationships between olfactory dysfunction and neurological / neurodegenerative diseases. Olfactory tests may have a role in … Continue reading
Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Parkinson's Disease, Quick Insights
Tagged Alzheimer’s Early Screening, Brazil, Dementia Screening, Department of Otorhinolaryngology: Faculdade de Medicina da Universidade de São Paulo, Early Screening, Faculdade de Medicina da Universidade de São Paulo, fMRI, Functional Magnetic Resonance Imaging (fMRI), Gender Differences in Human Olfactory Bulb, International Archives of Otorhinolaryngology, Loss of Sense of Smell, Neurodegeneration, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Olfaction (Sense of Smell), Olfaction and Neurodegenerative Diseases, Olfactory Discrimination and Cognitive Decline, Olfactory Dysfunction, Olfactory Epithelium Biopsy, Olfactory Tau Pathology in Alzheimer's Disease, Olfactory Tests, Olfactory Vector (Risk Factor) Hypothesis in Neurodegenerative Disease, Screening Tests
Leave a comment
National Screening for Dementia Not Recommended (UK NSC / AHRQ / Annals of Internal Medicine / Epidemiology / International Journal of Epidemiology)
Summary The UK National Screening Committee (UK NSC) has upheld previous recommendations against screening people aged 65 and over for dementia. This decision follows an extensive review of the evidence. The UK NSC has concluded that tests for dementia, which … Continue reading
Posted in Acute Hospitals, Community Care, Department of Health, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Guidelines, Models of Dementia Care, National, NHS, Patient Care Pathway, Person-Centred Care, Practical Advice, Public Health England, Quick Insights, Standards, UK, Universal Interest
Tagged (Hepatocellular Carcinoma: Alphafetoprotein), Activities of Daily Living (ADL), Activities of Daily Living Scale, ADAS-Cog, ADAS-Cog: Alzheimer’s Disease Assessment Scale - Cognitive Subscale, Addenbrooke's Cognitive Examination (ACE), Addenbrooke's Cognitive Examination-Revised (ACE-R), Alzheimer's Disease Assessment Scale (ADAS-Cog11), Alzheimer’s Early Screening, Annals of Internal Medicine, Australia, Benefits of Detection and Early Intervention, Best Interest Decisions, Best Interests, Best Interests of Patients, Blackfriars Consensus Statement, Bond University, Brief Assessments, Cambridge Cognitive Examination (CAMCOG), CAMCOG-R: Cambridge Cognitive Examination-Revised, Case Finding, Case Finding for Patients with Dementia, Centre for Research in Evidence-Based Practice: Bond University, CERAD-NP, Clock Drawing Test, Clock Drawing Test (CDT), Cognition Disorders, Cognitive Assessment Tools, Cognitive Impairment, Complex Best Interests Decision Making, Consortium to Establish a Registry for Alzheimer’s Disease – NP (CERAD-NP), Counter-Intuitive Screening Evidence, Counterintuitive Screening Evidence, Dementia Case Finding, Dementia Case Finding Scheme, Dementia Challenge, Dementia Diagnosis, Dementia Screening, Dementia Screening Debate, DemTect, Department of Medicine: Stanford University School of Medicine, Department of Statistics: Stanford University School of Humanities and Sciences, Diagnosis and Referral, Diagnosis and Support, Diagnosis Gap, Diagnosis of Dementia, Diagnosis Rates, Difficult Conversations, Doctor-Patient Relationships, Dr Anne Mackie: Director of Programmes (UK NSC), Dr Charles Alessi: Dementia Lead for PHE, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Screening, Effectiveness of Early Detection and Treatment, Ethical Considerations, Ethical Dilemmas, Ethical Issues of Dementia Care, Ethics and Decision-Making, General Practice, GPs, Harms of Detection and Early Intervention or Treatment, Improving Diagnosis, Incentive Payments, International Journal of Epidemiology, International Journal of Geriatric Psychiatry, Mass Screening, MCI: Mild Cognitive Impairment, Memory Assessments, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Montreal Cognitive Assessment (MoCA), Neuropsychological Tests, olutions for Public Health (SPH), Opinions About Meaning of Overdiagnosis: National Community Survey of Australians, PHE: Public Health England, Picture Based Assessments, Population Screening for Dementia Deyond Passive Case-Finding, Post-Diagnosis Support, Pre-Dementia (MCI), Prevalence of Cognitive Impairment, Primary Prevention Interventions, Prime Minister's Challenge on Dementia, Prime Minister’s Dementia Challenge, Progression of Mild Cognitive Impairment to Dementia, Quality Premium Payments, Recommendation against national dementia screening. London: Public Health England (PHE), Risk Assessment, Risk of Overdiagnosis Associated With Screening, Rowland Universal Dementia Assessment Scale (RUDAS), School of Public Health: University of Sydney, Screening, Screening for Cognitive Impairment, Screening for Cognitive Impairment in Older Adults, Screening for Dementia, Screening Programmes, Screening Tests, Screening: Counter-Intuitive Evidence, Screening: Counter-Intuitive Evidence (Abdominal Aortic Aneurysm), Screening: Counter-Intuitive Evidence (Abdominal Aortic Aneurysm: Ultrasound), Screening: Counter-Intuitive Evidence (Breast Cancer), Screening: Counter-Intuitive Evidence (Breast Cancer: Breast Self-Exam), Screening: Counter-Intuitive Evidence (Breast Cancer: Clinical Breast Exam), Screening: Counter-Intuitive Evidence (Breast Cancer: Mammography), Screening: Counter-Intuitive Evidence (Cardiovascular Disease), Screening: Counter-Intuitive Evidence (Cardiovascular Disease: Echocardiography), Screening: Counter-Intuitive Evidence (Cervical Cancer), Screening: Counter-Intuitive Evidence (Cervical Cancer: Cytology), Screening: Counter-Intuitive Evidence (Cervical Cancer: Human Papilloma Virus), Screening: Counter-Intuitive Evidence (Cervical Cancer: Visual Inspection), Screening: Counter-Intuitive Evidence (Colorectal Cancer), Screening: Counter-Intuitive Evidence (Colorectal Cancer: Faecal Occult Blood Test [FOBT]), Screening: Counter-Intuitive Evidence (Colorectal Cancer: Fecal Occult Blood Test [FOBT]), Screening: Counter-Intuitive Evidence (Colorectal Cancer: Flexible Sigmoidoscopy With or Without FOBT), Screening: Counter-Intuitive Evidence (Colorectal Cancer: Flexible Sigmoidoscopy), Screening: Counter-Intuitive Evidence (Colorectal Cancer: Single Flexible Sigmoidoscopy), Screening: Counter-Intuitive Evidence (Hepatocellular Carcinoma), Screening: Counter-Intuitive Evidence (Hepatocellular Carcinoma: Alphafetoprotein and Ultrasound), Screening: Counter-Intuitive Evidence (Lung Cancer), Screening: Counter-Intuitive Evidence (Lung Cancer: CA-125), Screening: Counter-Intuitive Evidence (Lung Cancer: Chest X-Ray), Screening: Counter-Intuitive Evidence (Lung Cancer: Chest X-Ray and Cytology), Screening: Counter-Intuitive Evidence (Lung Cancer: CT Scan), Screening: Counter-Intuitive Evidence (Multiple Flexible Sigmoidoscopy), Screening: Counter-Intuitive Evidence (Oral Cancer), Screening: Counter-Intuitive Evidence (Oral Cancer: Visual Exam), Screening: Counter-Intuitive Evidence (Ovarian Cancer), Screening: Counter-Intuitive Evidence (Ovarian Cancer: CA–125), Screening: Counter-Intuitive Evidence (Prostate Cancer), Screening: Counter-Intuitive Evidence (Prostate Cancer: Prostate-Specific-Antigen), Screening: Counter-Intuitive Evidence (Type 2 Diabetes), Screening: Counter-Intuitive Evidence (Type 2 Diabetes: Fasting Blood Glucose and HbA1c), Solutions for Public Health (SPH) Review, Stanford Prevention Research Center: Stanford University School of Medicine, Stanford University School of Medicine, Systematic Population Dementia Screening Programme: Not Recommended (UK NSC), Target Culture, Target-Driven Behaviour, Target-Driven Priorities, Targeted Screening, Timely Diagnosis, Trail Making Assessments, Trail Making Test, Trail Making Tests, Transition from Cognitive Impairment to Dementia, U.S. Preventive Services Task Force (USPSTF), UK National Screening Committee, UK National Screening Committee (UK NSC), United States Preventive Services Task Force, United States Preventive Services Task Force (USPSTF), University of Sydney, USA Department of Health Research and Policy, USA Department of Health Research and Policy: Stanford University School of Medicine, Verbal Fluency, Verbal Fluency Assessments
Leave a comment
Screening for Cognitive Impairment in Older Adults (USPSTF)
Summary The U.S. Preventive Services Task Force (USPSTF) recommendations on screening for cognitive impairment / dementia have been updated. USPSTF concludes that the evidence remains insufficient to assess the balance of benefits and harms regarding screening for cognitive impairment in … Continue reading
Posted in Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Quick Insights, Systematic Reviews
Tagged Agency for Healthcare Research and Quality (AHRQ), Agency for Healthcare Research and Quality (US), Alzheimer’s Early Screening, Benefits of Detection and Early Intervention, Case Finding, Case Finding for Patients with Dementia, Cognition Disorders, Cognitive Impairment, Dementia Case Finding, Dementia Screening, Dementia Screening Debate, Early Diagnosis, Early Screening, Effectiveness of Early Detection and Treatment, Harms of Detection and Early Intervention or Treatment, Mass Screening, Neuropsychological Tests, Risk Assessment, Screening for Cognitive Impairment, Screening for Cognitive Impairment in Older Adults, Screening Programmes, Screening Tests, Targeted Screening, U.S. Preventive Services Task Force (USPSTF), United States, United States Preventive Services Task Force, USA
Leave a comment